Submitted by Anonymous (not verified) on 19 August 2026 - 14:14
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 76, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 76, Status: Authorised